Back to User profile » Dr Charles L. Vogel
Paper published by Dr Charles L. Vogel:
Review
Addressing physician barriers to administering cyclin-dependent kinases 4 and 6 inhibitors in first-line treatment of hormone receptor–positive, human epidermal growth factor receptor 2–negative advanced breast cancer
Mahtani RL, Vogel CL
Cancer Management and Research 2019, 11:513-524
Published Date: 4 January 2019